ECSP992897A - Antagonistas del receptor de integrina - Google Patents
Antagonistas del receptor de integrinaInfo
- Publication number
- ECSP992897A ECSP992897A ECSP992897A ECSP992897A EC SP992897 A ECSP992897 A EC SP992897A EC SP992897 A ECSP992897 A EC SP992897A EC SP992897 A ECSP992897 A EC SP992897A
- Authority
- EC
- Ecuador
- Prior art keywords
- receptor antagonists
- integrin receptor
- alpha
- compounds
- present
- Prior art date
Links
- 229940127449 Integrin Receptor Antagonists Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 208000006386 Bone Resorption Diseases 0.000 abstract 1
- 206010012689 Diabetic retinopathy Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000024279 bone resorption Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 208000002780 macular degeneration Diseases 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a compuestos y derivados de los mismos, su sintesis, y su uso como antagonistas del receptor integrina. Más particularmente los compuestos de la presente invención son antagonistas de los receptores integrina alfa vB3, alfa v b5, y/o, av b6 y son útiles para inhibir la resorción ósea, tratar y prevenir osteoporosis, e inhibir la resyenosis vascular, retinopatia diabética, degeneración macular, angiogenésis, ateroesclerosis, inflamación, cicatrización de heridas, enfermedad viral y crecimiento de tumos y metástasis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP992897 ECSP992897A (es) | 1999-03-24 | 1999-03-24 | Antagonistas del receptor de integrina |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP992897 ECSP992897A (es) | 1999-03-24 | 1999-03-24 | Antagonistas del receptor de integrina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP992897A true ECSP992897A (es) | 1999-06-01 |
Family
ID=42043885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP992897 ECSP992897A (es) | 1999-03-24 | 1999-03-24 | Antagonistas del receptor de integrina |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP992897A (es) |
-
1999
- 1999-03-24 EC ECSP992897 patent/ECSP992897A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE298338T1 (de) | Integrin-rezeptor-antagonisten | |
| ATE294163T1 (de) | Integrin-rezeptor-antagonisten | |
| ATE299023T1 (de) | Integrinrezeptor antagonisten | |
| DK1187592T3 (da) | Alfa v-integrinreceptorantagonister | |
| ATE236626T1 (de) | Integrin antagonist | |
| ES2185009T3 (es) | Antagonistas de alfa y beta 3'. | |
| ATE353219T1 (de) | Alpha v integrin-rezeptor-antagonisten | |
| ECSP992897A (es) | Antagonistas del receptor de integrina | |
| YU38300A (sh) | Antagonisti integrinskog receptora | |
| YU38200A (sh) | Antagonisti integrinskog receptora | |
| ECSP003775A (es) | Antagonistas del receptor integrina alfa v |